[go: up one dir, main page]

CN1411380A - 含阿巴卡韦、拉米夫定和齐多夫定的均匀药物组合物 - Google Patents

含阿巴卡韦、拉米夫定和齐多夫定的均匀药物组合物 Download PDF

Info

Publication number
CN1411380A
CN1411380A CN99807983A CN99807983A CN1411380A CN 1411380 A CN1411380 A CN 1411380A CN 99807983 A CN99807983 A CN 99807983A CN 99807983 A CN99807983 A CN 99807983A CN 1411380 A CN1411380 A CN 1411380A
Authority
CN
China
Prior art keywords
pharmaceutical
pharmaceutical composition
lamivudine
zidovudine
abacavir
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN99807983A
Other languages
English (en)
Chinese (zh)
Inventor
R·柯里
S·杰恩
A·W·伍德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of CN1411380A publication Critical patent/CN1411380A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN99807983A 1998-04-29 1999-04-26 含阿巴卡韦、拉米夫定和齐多夫定的均匀药物组合物 Pending CN1411380A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9809213.3 1998-04-29
GBGB9809213.3A GB9809213D0 (en) 1998-04-29 1998-04-29 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
CN1411380A true CN1411380A (zh) 2003-04-16

Family

ID=10831228

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99807983A Pending CN1411380A (zh) 1998-04-29 1999-04-26 含阿巴卡韦、拉米夫定和齐多夫定的均匀药物组合物

Country Status (23)

Country Link
EP (1) EP1083932A1 (xx)
JP (1) JP2002512979A (xx)
KR (1) KR20010043128A (xx)
CN (1) CN1411380A (xx)
AP (1) AP2000001971A0 (xx)
AU (1) AU4135599A (xx)
BR (1) BR9910071A (xx)
CA (1) CA2330391A1 (xx)
EA (1) EA200000997A1 (xx)
EE (1) EE200000646A (xx)
GB (1) GB9809213D0 (xx)
HR (1) HRP20000732A2 (xx)
HU (1) HUP0101622A3 (xx)
ID (1) ID26955A (xx)
IL (1) IL139181A0 (xx)
IS (1) IS5675A (xx)
NO (1) NO20005418L (xx)
NZ (1) NZ507745A (xx)
PL (1) PL343710A1 (xx)
SK (1) SK16212000A3 (xx)
TR (1) TR200003157T2 (xx)
WO (1) WO1999055372A1 (xx)
ZA (1) ZA200005922B (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100335125C (zh) * 2003-06-03 2007-09-05 上海现代药物制剂工程研究中心 杀毒抗菌用长效干扰素喷鼻粉剂

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
EP1146882A2 (en) * 1998-05-29 2001-10-24 The University Of Florida Combination of zidovudine (azt) with nucleoside analogs for treatment of feline immunodeficiency virus
GB9820417D0 (en) * 1998-09-18 1998-11-11 Glaxo Group Ltd Antiviral combinations
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
BR0215707A (pt) * 2002-04-23 2005-05-03 Lupin Ltd Composição farmacêutica para a liberação controlada de ingredientes ativos e processo para a preparação de uma composição farmacêutica
TW200403061A (en) * 2002-06-04 2004-03-01 Glaxo Group Ltd Pharmaceutical compositions
US20110104267A1 (en) * 2005-04-25 2011-05-05 Aurobindo Pharma Limited Pharmaceutical compositions of antiretrovirals
WO2007013047A2 (en) * 2005-07-29 2007-02-01 Ranbaxy Laboratories Limited Water-dispersible anti-retroviral pharmaceutical compositions
ES2279707B1 (es) * 2005-11-10 2008-06-01 Combino Pharm, S.L. Formulaciones orales que comprenden 3'-azidonucleosidos.
CN101878032A (zh) * 2007-10-02 2010-11-03 埃默里大学 齐多夫定和针对hiv聚合酶中k65r突变选择的药剂的强力组合
GB2470494B (en) * 2008-01-17 2012-08-08 Univ Holy Ghost Duquesne Antiretroviral drug formulations for treatment of children exposed to HIV/AIDS
SMT201800290T1 (it) * 2010-01-27 2018-07-17 Viiv Healthcare Co Terapia antivirale
US20130115237A1 (en) 2010-06-09 2013-05-09 Vaccine Technologies, Incorporated Therapeutic immunization in hiv infected subjects to augment antiretroviral treatment
IN2014MN01907A (xx) 2012-03-05 2015-07-10 Cipla Ltd
NZ706223A (en) 2012-10-23 2018-11-30 Cipla Ltd Pharmaceutical antiretroviral composition
SG11201509998WA (en) 2013-06-13 2016-01-28 Akebia Therapeutics Inc Compositions and methods for treating anemia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY115461A (en) * 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc
GB9622681D0 (en) * 1996-10-31 1997-01-08 Glaxo Group Ltd Pharmaceutical compositions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100335125C (zh) * 2003-06-03 2007-09-05 上海现代药物制剂工程研究中心 杀毒抗菌用长效干扰素喷鼻粉剂

Also Published As

Publication number Publication date
JP2002512979A (ja) 2002-05-08
HUP0101622A3 (en) 2003-09-29
SK16212000A3 (sk) 2001-07-10
EA200000997A1 (ru) 2001-06-25
HRP20000732A2 (en) 2001-02-28
NO20005418D0 (no) 2000-10-27
AP2000001971A0 (en) 2000-12-31
ID26955A (id) 2001-02-22
HUP0101622A2 (hu) 2002-03-28
IS5675A (is) 2000-10-20
NZ507745A (en) 2004-07-30
IL139181A0 (en) 2001-11-25
AU4135599A (en) 1999-11-16
TR200003157T2 (tr) 2001-01-22
GB9809213D0 (en) 1998-07-01
EE200000646A (et) 2002-04-15
NO20005418L (no) 2000-11-29
PL343710A1 (en) 2001-08-27
ZA200005922B (en) 2001-10-23
CA2330391A1 (en) 1999-11-04
KR20010043128A (ko) 2001-05-25
BR9910071A (pt) 2000-12-26
EP1083932A1 (en) 2001-03-21
WO1999055372A1 (en) 1999-11-04

Similar Documents

Publication Publication Date Title
EP1583542B1 (en) Compositions and methods for combination antiviral therapy
CN1411380A (zh) 含阿巴卡韦、拉米夫定和齐多夫定的均匀药物组合物
CN1103593C (zh) 协同组合物
CN1051550C (zh) 作为抗病毒剂的4－[2－氨基－6－(环丙基氨基)－9h－嘌呤－9－基]－2－环戊烯－1－甲醇琥珀酸盐
JP2025084892A (ja) 異常な細胞成長を処置するための組成物および方法
EP1567133B1 (en) Pharmaceutical antiviral compositions
EP0941100B1 (en) Pharmaceutical compositions containing lamivudine and zidovudine
CN1303284A (zh) 8－氯－6,11－二氢－11－(4－亚哌啶基)－5H－苯并[5,6]环庚三烯并[1,2－b]吡啶口服组合物
US20050171127A1 (en) Pharmaceutical compositions comprising abacavir and lamivudine
CN1314400C (zh) 复方甲氧那明口服固体制剂及其制备方法
CZ20003998A3 (cs) Farmaceutický prostředek
MXPA00010498A (en) Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine
JP2002526449A (ja) ラミブジンおよびアバカビルを含んでなる抗ウイルス性組合せ製剤
RU2586290C1 (ru) Твердая лекарственная форма прокарбазина немедленного высвобождения и способ ее получения
CN1257431A (zh) 化学和热稳定的诺尔阿司咪唑制剂
HK1079122B (en) Compositions and methods for combination antiviral therapy
CN1241142A (zh) 含有拉米夫定和齐多夫定的药用组合物
HK1009401B (en) Synergistic combinations
MXPA99004025A (en) Pharmaceutical compositions containing lamivudine and zidovudine
HK1020880B (en) Pharmaceutical compositions containing lamivudine and zidovudine
CN1370538A (zh) 含有司他夫定和双脱氧肌苷的药用组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication